🔗 Permalink

Inventor profile of:

Benjamin E. Blass

City:

Eagleville, Pennsylvania

Country:

United States

Published Applications:

Last publication date:

2025-09-11

Top Assignees for applications by Benjamin E. Blass

The entities that hold a legal rights for patent applications filed by inventor Blass Benjamin E.:

Temple University of the Commonwealth System of Higher Education 19 Philadelphia, PA United States
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 4 New Brunswick, NJ United States
Biohaven Pharmaceutical Holding Company Ltd. 4 New Haven, CT United States
Wyeth 3 Madison, NJ United States
Praeventix, LLC 3 Exton, PA United States
Temple University-Of The Commonwealth System Higher Education 1 Philadelphia, PA United States
Wyeth LLC 1 Madison, NJ United States
Biohaven Pharmaceutical Holding Company Limited 1 New Haven, CT United States

Recent patent applications by Blass Benjamin E.

Benjamin E. Blass from Eagleville, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-09-11

US20250282790A1

Chemistry; metallurgy

NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

#2 | 2024-12-26

US20240425487A1

Chemistry; metallurgy

NOVEL 5-HYDROXYTRYPTAMINE RECEPTOR 7 ACTIVITY MODULATORS AND THEIR METHOD OF USE

#3 | 2024-09-12

US20240300954A1

Chemistry; metallurgy

NOVEL MODULATORS OF THE SIGMA-2 RECEPTOR AND THEIR METHOD OF USE

#4 | 2024-09-12

US20240300953A1

Chemistry; metallurgy

5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THEIR USE AS THERAPEUTIC AGENTS

#5 | 2023-06-29

US20230202993A1

Chemistry; metallurgy

Prodrugs of riluzole and their method of use

#6 | 2023-04-13

US20230112888A1

Chemistry; metallurgy

NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

#7 | 2023-01-05

US20230002383A1

Chemistry; metallurgy

NOVEL FUNCTIONALIZED LACTAMS AS MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE

#8 | 2022-11-03

US20220348581A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

#9 | 2022-09-29

US20220306596A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#10 | 2022-05-05

US20220133713A1

Human necessities

SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE

#11 | 2021-11-25

US20210363145A1

Chemistry; metallurgy

Modulators of the sigma-2 receptor and their method of use

#12 | 2021-08-05

US20210238189A1

Chemistry; metallurgy

Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

#13 | 2021-03-18

US20210078962A1

Chemistry; metallurgy

Prodrugs of riluzole and their method of use

#14 | 2020-10-22

US20200331915A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

#15 | 2020-10-08

US20200317648A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#16 | 2020-07-16

US20200223810A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#17 | 2020-05-21

US20200157069A1

Chemistry; metallurgy

Prodrugs of riluzole and their method of use

#18 | 2020-02-06

US20200039985A1

Chemistry; metallurgy

Modulators of the sigma-2 receptor and their method of use

#19 | 2019-12-05

US20190367528A1

Chemistry; metallurgy

Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

#20 | 2019-12-05

US20190367493A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#21 | 2019-05-02

US20190127323A1

Chemistry; metallurgy

Beta lactams as modulators of glutamate uptake and methods for use thereof

#22 | 2018-08-09

US20180221365A1

Human necessities

NOVEL SIGMA-2 RECEPTOR BINDERS AND THEIR METHOD OF USE

#23 | 2018-01-18

US20180016262A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#24 | 2018-01-18

US20180016261A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#25 | 2017-11-23

US20170334870A1

Chemistry; metallurgy

Prodrugs of riluzole and their method of use

#26 | 2016-08-11

US20160229841A1

Chemistry; metallurgy

Beta lactams as modulators of glutamate uptake and methods for use thereof

#27 | 2016-01-21

US20160016941A1

Chemistry; metallurgy

5-hydroxytryptamine receptor 7 activity modulators and their method of use

#28 | 2015-10-15

US20150291539A1

Chemistry; metallurgy

Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2B activity modulators

#29 | 2015-02-12

US20150045401A1

Chemistry; metallurgy

Prodrugs of riluzole and their method of use

#30 | 2009-03-12

US20090069342A1

Chemistry; metallurgy

Kv1.5 potassium channel inhibitors

#31 | 2007-12-27

US20070299120A1

Chemistry; metallurgy

Kv1.5 potassium channel inhibitors

#32 | 2007-12-27

US20070299072A1

Chemistry; metallurgy

KV1.5 POTASSIUM CHANNEL INHIBITORS

InventorID:

1320821 ⎘